Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation 

Published byΕυτύχιος Νικολαΐδης Modified over 6 years ago

Similar presentations

Presentation on theme: "Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation "— Presentation transcript:

1 Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation  Sophie Malekzadeh-Milani, MD, Magalie Ladouceur, MD, Laurence Iserin, MD, Damien Bonnet, MD, PhD, Younes Boudjemline, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 148, Issue 5, Pages (November 2014) DOI: /j.jtcvs Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Freedom from infective endocarditis in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. IE, Infective endocarditis; PPVI, percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Survival curve in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. PPVI, Percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Freedom from cardiovascular events in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. PPVI, Percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation "

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Challenging homografts as the holy grail for aortic valve endocarditis

Challenging homografts as the holy grail for aortic valve endocarditis
Surgery for congenital diseases of the aorta

Surgery for congenital diseases of the aorta
In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.
Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients  Björn.
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Pulmonary hypertension in valve disease: A beast of the past?

Pulmonary hypertension in valve disease: A beast of the past?
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.

Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function

Form ever follows function
William M. DeCampli, MD, PhD 

William M. DeCampli, MD, PhD 
Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease  Nobuyuki Ishibashi, MD, Richard A. Jonas,
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 

Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.

Similar presentations

Ads by Google